<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9432918</journal-id>
<journal-id journal-id-type="nlm-ta">Immunity</journal-id>
<journal-id journal-id-type="iso-abbrev">Immunity</journal-id>
<journal-title-group>
<journal-title>Immunity</journal-title>
</journal-title-group>
<issn pub-type="ppub">1074-7613</issn>
<issn pub-type="epub">1097-4180</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30995499</article-id>
<article-id pub-id-type="pmc">7174020</article-id>
<article-id pub-id-type="doi">10.1016/j.immuni.2019.03.012</article-id>
<article-id pub-id-type="manuscript">EMS86224</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>IL-1 and related cytokines in innate and adaptive immunity in health and disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mantovani</surname>
<given-names>Alberto</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dinarello</surname>
<given-names>Charles A.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Molgora</surname>
<given-names>Martina</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garlanda</surname>
<given-names>Cecilia</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>IRCCS Humanitas Clinical and Research Center, via Manzoni 56, 20089 Rozzano (Milan), Italy</aff>
<aff id="A2">
<label>2</label>Humanitas University, via Rita Levi Montalcini, 20090 Pieve Emanuele (Milan), Italy</aff>
<aff id="A3">
<label>3</label>The William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ</aff>
<aff id="A4">
<label>4</label>Department of Medicine, University of Colorado Denver, Aurora, CO 80045 USA</aff>
<aff id="A5">
<label>5</label>Department of Medicine, Radboud University Medical Center, Nijmegen, The Netherlands</aff>
<author-notes>
<corresp id="CR1">Corresponding author: Alberto Mantovani, <email>alberto.mantovani@humanitasresearch.it</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>16</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>4</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>21</day>
<month>4</month>
<year>2020</year>
</pub-date>
<volume>50</volume>
<issue>4</issue>
<fpage>778</fpage>
<lpage>795</lpage>
<!--elocation-id from pubmed: 10.1016/j.immuni.2019.03.012-->
<abstract>
<p id="P1">Forty years after its naming, IL-1 and related cytokines experience a renaissance as central mediators of inflammation and immunity. IL-1 family members, including IL-18, IL-33, IL-36, IL-37, and IL-38, play a key role in the orchestration of the diversity and plasticity of innate and adaptive immune responses. As such, these molecules are involved in homeostasis and in a range of pathologies, ranging from autoimmunity and autoinflammation, to dysmetabolism and cardiovascular disorders, to cancer. Dissection of the complexity and role in immunopathology of the IL-1 family has paved the way to development of trans-disease therapeutic strategies. Therefore, IL-1 serves as a paradigm for immunity and inflammation representing a metanarrative of modern medicine.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>